ESR1 and breast cancer: There was no significant difference in OS between SLNB and ALND in patients with pT0–T2 ER+ HER2− breast cancer with 3–5 positive lymph nodes who underwent adjuvant chemotherapy, endocrine therapy, and radiation treatment on Kaplan–Meier analysis (Fig. 3).